GZERO Media logo
{{ subpage.title }}

Texas grid shows need to fix infrastructure in US; RIP Rush Limbaugh

Ian Bremmer discusses the World In (more than) 60 Seconds:

What's happening in Texas?

Speaking of weird weather, my goodness yeah, I didn't know this was coming up here. Yeah, it's cold, right? There's snow. It looks horrible and millions of people without energy and of course that is because the level of infrastructure investment into the Texas grid is well below what it needs to be. There's a lack of integration. Texas' grid largely stands by itself. It is not under the authority of or coordinated multilaterally with broader energy infrastructure. And there has been a lot of investment into renewables in Texas. It is certainly true. They've been very interested in that. Sped up under former Governor Perry but still the vast majority of electricity is coming from fossil fuels. It's coming from coal and mostly oil and gas.

Read Now Show less

Getting vaccine distribution right: ideas from health expert Dr. Atul Gawande

When Boston-based surgeon and public health expert Dr. Atul Gawande talks about vaccinating the American public, he's not speaking in hypotheticals. "I'm running vaccine distribution right now with a team of people and a partnership I've put together at Gillette Stadium, Fenway Park, and beyond." And the most important thing about vaccine distribution that Dr. Gawande has learned so far is to know how much vaccine is coming and when. Dr. Gawande's experience has also revealed a fundamental truth about the American health care system: "We're all breakthrough and no follow through." What can be done to get more vaccines into more arms before COVID-19 variants take hold? Dr. Gawande has a variety of ideas and he shares them with Ian Bremmer on GZERO World.

Watch the episode: The race to vaccinate

The Race To Vaccinate: Dr. Atul Gawande Provides Perspective

Can the US vaccinate enough of its population to prevent hundreds of thousands of deaths before new and more contagious COVID-19 variants take hold? And will these vaccines even be effective against more adaptable mutations of the virus? Surgeon and public health expert Dr. Atul Gawande, most recently of the Biden/Harris COVID-19 Transition Task Force, joins Ian Bremmer on GZERO World to discuss the latest in the global effort to vaccinate our way out of this pandemic. He also explains why people should get the Johnson & Johnson vaccine if offered the chance, despite its lower overall efficacy rate compared to the mRNA-based vaccines from Pfizer and Moderna.

Congress after the attempt to overthrow democracy: Democratic Senator Chris Murphy

Two-term Democratic Senator Chris Murphy of Connecticut joins Ian Bremmer to talk about his harrowing experience during the Capitol riots of January 6, why he thinks an impeachment trial is still valuable even if Republican support for a conviction looks increasingly unlikely, if he believes President Biden's $1.9 trillion stimulus package will pass both chambers, and how he thinks US-China foreign policy should change under the new administration.

Watch this extended interview from the recent episode of GZERO World: After the insurrection: will Congress find common ground?

Podcast: The race to vaccinate

Listen: Can the United States vaccinate enough of its population to prevent hundreds of thousands of deaths before new and more contagious COVID-19 variants take hold? And will these vaccines even be effective against more adaptable mutations of the virus? Surgeon and public health expert Dr. Atul Gawande, most recently of the Biden/Harris COVID-19 Transition Task Force, joins the podcast to discuss the latest in the global effort to vaccinate our way out of this pandemic. He also explains why people should get the Johnson & Johnson vaccine if offered the chance, despite its lower overall efficacy rate compared to the mRNA-based vaccines from Pfizer and Moderna.

Subscribe to the GZERO World Podcast on Apple Podcasts, Spotify, Stitcher, or your preferred podcast platform to receive new episodes as soon as they're published.

Latest